Iambic Therapeutics获Ark Investment与Duquesne Family Office青睐,拟按IPO价格认购至多6000万美元股份

美股速递
Oct 08

Iambic Therapeutics Inc. 在首次公开募股中获得了来自 Ark Investment 和 Duquesne Family Office 的认购意向。这两家机构表示,有意按 IPO 发行价购买至多 6000 万美元的股份。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10